Holistic and Alternative Medicine

New Clinical Study Shows Pistachio-Derived Melatonin Matches Synthetic Supplements in Improving Sleep Quality

Recent advancements in nutritional science have opened new avenues for natural sleep aids, centered around an unexpected source: the common

pistachio nut. Researchers in Australia have published findings demonstrating that a novel, pistachio-derived melatonin extract performs comparably to widely available synthetic melatonin supplements in improving short-term sleep parameters among adults with mild sleep impairments.

The clinical trial, conducted by Brisbane-based research organization RDC Clinical in collaboration with the University of Queensland, investigated an active-control crossover design involving a plant-derived supplement known as Prosomnial. Developed by the Australian nutritional ingredient company Network Nutrition, the extract utilizes specific cultivars of Pistacia vera—commonly known as pistachios—which naturally produce high levels of phytomelatonin.

Background and the Rising Demand for Natural Sleep Solutions

The market for sleep aids has expanded significantly in recent years, driven by a growing prevalence of chronic sleep disorders. According to a 2024 survey conducted by the American Academy of Sleep Medicine, approximately 12 percent of the United States adult population has been diagnosed with chronic insomnia. Concurrently, the broader U.S. sleep supplement market is projected to reach $1.45 billion in sales by 2029, with melatonin-based products commanding a major segment of consumer spending.

Despite this commercial popularity, the supplement industry faces ongoing scrutiny regarding product quality, variable dosing consistency, and the safety of self-diagnosed and self-prescribed melatonin use, particularly among vulnerable populations such as children. These concerns have fueled consumer demand for standardized, natural, and clinically validated alternatives to synthetic pharmaceuticals and unregulated herbal preparations.

Phytomelatonin—naturally occurring melatonin found in plants—offers a botanical alternative. While melatonin is traditionally recognized as an indolamine hormone synthesized primarily by the pineal gland, certain plant species accumulate significant concentrations of the molecule. Melatonin regulates circadian rhythms by binding to high-affinity MT1 and MT2 receptors located within the suprachiasmatic nucleus of the brain and peripheral tissues. Activation of MT1 receptors helps suppress neural firing to promote sleep initiation, while MT2 receptor activation synchronizes circadian rhythms with environmental light-dark cycles.

Chronology and Methodology of the Clinical Trial

To evaluate the comparative efficacy and absorption kinetics of plant-derived melatonin versus its synthetic counterpart, researchers designed a rigorous, active-control crossover trial. The study enrolled 26 generally healthy adults with a mean age of 31 years who suffered from mild but chronic sleep impairment, defined primarily by prolonged sleep latency (wakefulness greater than 20 minutes when attempting to fall asleep).

Participants met strict inclusion criteria: they were not using any prescription sleep medications, anxiety-related pharmaceuticals, or competing dietary supplements, and they lacked underlying medical conditions that could confound sleep assessments.

The trial followed a randomized, active-controlled protocol divided into two distinct seven-day treatment phases separated by a 14-day washout period:

Pistachio-Derived Melatonin Improves Sleep Quality
  • Intervention Phase One: Participants were randomized to ingest either a 100 mg dose of Prosomnial (delivering 1 mg of plant-derived melatonin) or an equivalent 100 mg dose of synthetic melatonin formatted as a visually identical gummy. Supplements were administered nightly, exactly one hour prior to bedtime.
  • Washout Period: A mandatory 14-day interval without any trial supplementation to clear systemic melatonin levels.
  • Intervention Phase Two: Participants crossed over to receive the alternative supplement for an additional seven days.

Throughout the study, participants completed daily self-assessed sleep diaries and attended multiple in-person clinic visits supported by interim telephonic check-ins. During clinic visits following each treatment phase, fasting blood samples were collected to measure baseline and post-dose plasma melatonin kinetics at intervals of 10, 20, 30, 45, and 60 minutes following ingestion.

Pharmacokinetic and Clinical Outcomes

The analysis revealed no statistically significant differences in absorption kinetics between the two supplements. While the synthetic melatonin demonstrated a minor trend toward higher peak plasma concentrations, the overall area under the curve (AUC) for absorption from zero to two hours was 5,994 pg·h/mL for Prosomnial compared to 7,425 pg·h/mL for the synthetic comparator (P = 0.39). Furthermore, the time required to reach maximum plasma concentration was nearly identical, recorded at 75 minutes for the pistachio extract and 60 minutes for the synthetic product (P = 0.93).

Regarding clinical sleep parameters, both formulations delivered notable benefits without any reported adverse safety events or product-related side effects.

Principal investigators Amanda Rao, PhD, and David Briskey noted that the pistachio-derived supplement was associated with statistically significant improvements from baseline across multiple metrics, including sleep latency, total sleep time, overall sleep quality, and the subjective feeling of being rested upon waking. The synthetic melatonin comparator successfully reduced the number of nighttime awakenings and increased morning alertness, though it did not produce statistically significant changes in sleep latency or total sleep time within this specific cohort. Neither supplement significantly altered daytime nap frequency or duration compared to baseline values.

Implications and Limitations of the Research

The findings suggest that plant-derived melatonin can serve as a viable, clinically equivalent alternative for individuals seeking natural options to manage mild sleep-onset difficulties.

However, the study authors acknowledged several methodological limitations. The trial was relatively short in duration, evaluated a healthy cohort without severe chronic insomnia, relied partially on subjective self-reporting for sleep outcomes, and lacked a placebo control arm to isolate placebo effects from active treatment responses. Additionally, the research was funded by Network Nutrition, highlighting the necessity for independent, long-term replication studies.

Can Consumers Achieve Clinical Benefits Solely Through Diet?

The identification of high phytomelatonin concentrations in pistachios naturally prompts questions regarding whether individuals can achieve therapeutic effects simply by increasing their dietary intake of the nuts.

Scientific literature indicates that melatonin content in pistachios varies widely depending on cultivar species, geographic growing conditions, post-harvest processing methods, and whether the nuts are consumed raw or roasted. While historical analyses suggest that certain 3.5-ounce (100-gram) servings of shelled pistachios can yield up to 23 mg of melatonin—substantially higher than typical low-dose commercial supplements—relying on whole foods alone may be insufficient for individuals requiring a rapid circadian reset for clinical insomnia.

Nevertheless, for individuals managing mild sleep irregularities who prefer a food-first lifestyle approach, incorporating a standard one-ounce serving of pistachios (approximately 50 nuts) before bed provides a practical dietary strategy. Beyond their natural melatonin content, pistachios supply beneficial levels of magnesium and vitamin B6, both of which support muscular relaxation and neurochemical pathways conducive to restorative sleep.

Related Articles

Back to top button